Mulmit

Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.

ATRA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31120,772,00035,862,00032,688,0002.57
2024-12-31128,940,000-83,438,000-85,403,000-11.41
2023-12-318,573,000-276,006,000-276,126,000-65.19

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-04Cherry Brian N104,166
2026-08-17Nguyen AnhCoPresident and CEO5,062
2026-07-22Redmile Group, LLC195,211
2026-07-22Redmile Group, LLC60
2026-07-22Redmile Group, LLC101,089
2026-07-22Redmile Group, LLC38,735
2026-07-22Redmile Group, LLC55,387
2026-06-11Cherry Brian N24,000
2026-06-09HEIDEN WILLIAM K12,000
2026-06-09Fust Matthew K12,000
2026-06-09Ciongoli Gregory AustinSee Remarks12,000
2026-05-18Nguyen AnhCoPresident and CEO5,241

8-K events

FiledItems
2026-08-12Results of operations
2026-06-26Officer or director change
2026-06-12Officer or director change · Submission of matters to a vote
2026-05-12Financial statements and exhibits
2026-05-07Other events
2026-05-01Delisting or listing-standard notice
2026-03-16Results of operations · Financial statements and exhibits
2026-03-12Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.